Seventeen terminally ill cancer patients with primary or secondary intra- thoracic malignancy complaining of breathlessness were treated with nebulized morphine in doses of 20 mg 4-hourly for 48 h. The effect on dyspnoea was evaluated using the Dyspnoea Assessment Questionnaire. Most patients felt less dyspnoeic after 24 h; the effect was maintained, but not improved upon, after 48 h.
Reuben DB, Mor V.Dyspnea in terminally ill cancer patients. Chest1986; 89: 234-36.
2.
Heyse-Moore LH, Ross V., Mullee MAHow much of a problem is dyspnoea in advanced cancer? Palliat Med1991; 5: 20-26.
3.
Ahmedzai S.Palliation of respiratory symptoms. In: Doyle D, Hanks GWC, MacDonald N eds. Oxford textbook of palliative medicine . Oxford; Oxford University Press , 1993: 349-77.
4.
Higginson I. , McCarthy M.Measuring symptoms in terminal cancer; are pain and dyspnoea controlled?J R Soc Med1989; 82: 264-67.
5.
Muers MFRound CE on behalf of the group. Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group. Thorax1993; 48: 339-43.
6.
Rogers DF, Barnes PJOpioid inhibition of neurally mediated mucus secretion in human bronchi. Lancet1989; i: 930-31.
Young IH, Daviskas E., Keena VAEffect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease. Thorax1989; 44: 387-90.
9.
Davis CL, Lam W., Roberts M., Daniels J., Joel SP, Slevin MLThe pharmacokinetics of nebulised morphine. Proceedings of the International Association for the Study of Pain. Abstract 995. SeattleIASP Publications, 1993: 379.
10.
Farncombe M.Chater S.Case studies outlining use of nebulised morphine for patients with endstage chronic lung and cardiac disease. J Pain Symp Management1993; 8: 221-25.
11.
Beauford W. , Saylor TT, Stansbury DW, Avalos K., Light RWEffects of nebulised morphine sulfate on the exercise tolerance of the ventilatory limited COPD patient. Chest1993; 104: 175-8.
12.
Tooms A., McKenzie A., Grey H.Nebulised morphine. Lancet1993; 342: 1123-24.
13.
Davis CL, Hodder CA, Love S., Shah R., Slevin SL, Wedzicha A.Effects of nebulised morphine and morphine-6-glucuronide on exercise endurance in patients with chronic obstructive airways disease. Thorax1994; 49: 393P.
14.
Farncombe M. , Chater S., Gillis A.The use of nebulised opioids for breathlessness: a chart review. Palliat Med1994; 8: 306-12.
15.
Masood AR, Reed JW, Thomas Shl.Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease. Thorax1995 ; 50: 629-34.
16.
Davis CL, Penn K., AHern R., Daniels J., Slevin M.Single dose randomised controlled trial of nebulised morphine in patients with cancer related breathlessness. Research abstract from Palliative Care Research Forum 8-9 November 1995. Palliat Med1996; 10: 64.
17.
Leung R., Hill P., Burdon J.Effect of inhaled morphine on the development of breathlessness during exercise in patients with chronic lung disease. Thorax1996; 51: 596-600.
18.
Davis CLThe use of nebulised morphine for breathlessness. Palliat Med1995; 9: 169-70.
19.
Davis CLThe role of nebulised drugs in palliating respiratory symptoms of malignant disease. Eur J Palliat Care1995; 2: 9-15.
20.
Heyse-Moore LHOn dyspnoea in advanced cancer. DM thesis. Southampton : University of Southampton, 1993 .
21.
Melzack R. TheMcGill Pain Questionnaire: major properties and scoring methods. Pain1975; 1: 277-99.
22.
Wilcock A., Corcoran R., Tattersfield AESafety and efficacy of nebulised lignocaine in patients with cancer and breathlessness . Palliat Med1994; 8: 35-38.
23.
Pedersen S.Inhalers and nebulisers: which to use and why . Resp Med1996; 90: 69-77.
24.
Wood JA, Wilson Rse, Bray C.Changes in salbutamol concentration in the reservoir solution of a jet nebuliser . Br J Dis Chest1986; 80: 164-69.
25.
Clay MM, Pavia D., Newman SP, Lennard-Jones TR, Clarke SWAssessment of jet nebulisers for lung aerosol therapy. Lancet1983; ii: 592-94.
26.
Hughes S., Calverly Pma.Heroin inhalation and asthma. Br Med J1988 ; 297: 1511-12.
27.
Masters NJ, Bennett Mrd, Wedley JRNebulised morphine: a new delivery method for pain relief. Practitioner1985; 229: 649-53.
